This study presents a light-driven microrobot for precise nanoparticle manipulation, utilizing plasmonic nanomotors to ...

Talking about zoom levels, the long-range periscope-style telephoto camera could also go from 5x to 8x optical zoom range, and a wider aperture to go with it. As usual, optical image stabilization ...

The F7 Ultra’s rear camera array includes a 50 megapixel main camera at a fast aperture of f/1.6, a 50MP 2.5x telephoto camera, and a 32MP ultrawide — plus another 32MP camera for selfies.

Prosecutors have also indicated they plan to bolster their theory of the alleged collision with help from experts at Aperture, a company that deals in accident reconstruction and biomechanics.

“The new iPad’s best trait is an unchanged asking price, despite doubling the storage and serving a faster chip. It’s a polished package that doesn’t disappoint.” With the 11th ...

Write to [email protected] Cassava Sciences NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

The last time a new class of antibiotics reached the market was nearly three decades ago - but that could soon change, thanks to a discovery by researchers at McMaster University. The Chan ...

It seems a team of researchers announced they'd used SAR (Synthetic Aperture Radar) to reveal a number of underground buildings beneath the Khafre Pyramid. This discovery could offer proof the ...

NTT DATA Business Solutions UK&I are proud to announce a partnership with Airbus owned, Surrey Satellite Technologies Ltd (SSTL), a long-time pioneer of small satellite and spacecrafts, as they ...

Today’s health and medical science professionals need to be proficient in their chosen field, committed to helping others, and driven to take on the unique and ever-changing challenges facing modern ...

Research from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago strongly suggests that Kawasaki disease is caused by a single respiratory virus ...

Cassava Sciences (SAVA) shared topline results from the Phase 3 REFOCUS-ALZ study of simufilam in mild-to-moderate AD. Topline data indicate that REFOCUS-ALZ did not meet each of the prespecified ...